Literature DB >> 25150587

Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure.

Yoichi Takaya1, Fumiki Yoshihara2, Hiroyuki Yokoyama1, Hideaki Kanzaki1, Masafumi Kitakaze1, Yoichi Goto1, Toshihisa Anzai1, Satoshi Yasuda1, Hisao Ogawa1, Yuhei Kawano3.   

Abstract

Since acute kidney injury (AKI) is not always related to mortality in patients with acute decompensated heart failure (ADHF), the aim of this study was to focus on onset time of AKI and its clinical importance. A total of 371 ADHF patients were included. The impact of AKI (≥ 0.3 mg/dl or 1.5-fold increase in serum creatinine level within 48 h) with early onset (≤ 4 days from admission) or late onset (≥ 5 days from admission) was assessed. AKI occurred in 99 patients, who were divided into two groups according to the median onset time of AKI: 50 with early onset of AKI and 49 with late onset of AKI. The maximum increase in serum creatinine level from admission was greater in patients with late onset of AKI than in patients with early onset of AKI (p = 0.012). Patients with late onset of AKI had a higher 12-month mortality rate than that in patients with early onset of AKI (log-rank test, p = 0.014). Late onset of AKI was an independent predictor of mortality (hazard ratio: 3.39, 95 % confidence interval: 1.84-6.18, p < 0.001). Late onset of AKI was associated with high blood urea nitrogen level at admission and intravenous administration of dobutamine. In conclusion, late onset of AKI related to high blood urea nitrogen level and intravenous administration of dobutamine, but not early onset of AKI, is linked to high mortality rate. Onset time of AKI may be useful for risk stratification of mortality in ADHF patients developing AKI.

Entities:  

Keywords:  Acute decompensated heart failure; Acute kidney injury; Onset time; Prognosis

Mesh:

Substances:

Year:  2014        PMID: 25150587     DOI: 10.1007/s00380-014-0572-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

1.  Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.

Authors:  Marco Metra; Beth Davison; Luca Bettari; Hengrui Sun; Christopher Edwards; Valentina Lazzarini; Barbara Piovanelli; Valentina Carubelli; Silvia Bugatti; Carlo Lombardi; Gad Cotter; Livio Dei Cas
Journal:  Circ Heart Fail       Date:  2011-12-13       Impact factor: 8.790

2.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

3.  Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

Authors:  Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen
Journal:  Eur Heart J       Date:  2005-01-28       Impact factor: 29.983

4.  Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure.

Authors:  Harini Chittineni; Nobuyuki Miyawaki; Sailaja Gulipelli; Steven Fishbane
Journal:  Am J Nephrol       Date:  2007-01-24       Impact factor: 3.754

5.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

6.  Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.

Authors:  Marco Metra; Christopher M O'Connor; Beth A Davison; John G F Cleland; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Michael M Givertz; George A Mansoor; Daniel M Bloomfield; Gang Jia; Paul DeLucca; Barry Massie; Howard Dittrich; Gad Cotter
Journal:  Eur Heart J       Date:  2011-03-08       Impact factor: 29.983

Review 7.  Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?

Authors:  Robert W Schrier
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

8.  Relation of blood urea nitrogen to long-term mortality in patients with heart failure.

Authors:  Clay A Cauthen; Michael J Lipinski; Antonio Abbate; Darryn Appleton; Annunziata Nusca; Amit Varma; Evelyne Goudreau; Michael J Cowley; George W Vetrovec
Journal:  Am J Cardiol       Date:  2008-04-09       Impact factor: 2.778

9.  Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Authors:  Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  9 in total

1.  Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses.

Authors:  Masataka Ogiso; Toshiaki Isogai; Yuta Okabe; Kansuke Ito; Masaki Tsuji; Hiroyuki Tanaka
Journal:  Heart Vessels       Date:  2017-02-20       Impact factor: 2.037

2.  Prognostic impact of disseminated intravascular coagulation score in acute heart failure patients referred to a cardiac intensive care unit: a retrospective cohort study.

Authors:  Ryosuke Itani; Yuichiro Minami; Shintaro Haruki; Erisa Watanabe; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2017-01-24       Impact factor: 2.037

3.  Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide.

Authors:  Yoichi Takaya; Fumiki Yoshihara; Hiroyuki Yokoyama; Hideaki Kanzaki; Masafumi Kitakaze; Yoichi Goto; Toshihisa Anzai; Satoshi Yasuda; Hisao Ogawa; Yuhei Kawano; Kenji Kangawa
Journal:  Heart Vessels       Date:  2017-02-07       Impact factor: 2.037

4.  Association between absolute blood eosinophil count and CKD stages among cardiac patients.

Authors:  Rui Ishii; Shu-Ichi Fujita; Shun Kizawa; Kazushi Sakane; Hideaki Morita; Michishige Ozeki; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  Heart Vessels       Date:  2014-10-18       Impact factor: 2.037

5.  Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease.

Authors:  Yusuke Uemura; Rei Shibata; Kenji Takemoto; Tomohiro Uchikawa; Masayoshi Koyasu; Shinji Ishikawa; Takayuki Mitsuda; Ayako Miura; Ryo Imai; Satoshi Iwamiya; Yuta Ozaki; Tomohiro Kato; Takanori Miura; Masato Watarai; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2015-11-28       Impact factor: 2.037

6.  Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.

Authors:  Yoshitaka Okuhara; Shinichi Hirotani; Tomotaka Ando; Koichi Nishimura; Yoshiyuki Orihara; Kazuo Komamura; Yoshiro Naito; Toshiaki Mano; Tohru Masuyama
Journal:  Heart Vessels       Date:  2016-07-28       Impact factor: 2.037

7.  Prevalence, implication, and determinants of worsening renal function after surgery for congenital heart disease.

Authors:  Hirofumi Saiki; Seiko Kuwata; Clara Kurishima; Yoichi Iwamoto; Hirotaka Ishido; Satoshi Masutani; Hideaki Senzaki
Journal:  Heart Vessels       Date:  2015-08-13       Impact factor: 2.037

8.  Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure.

Authors:  Ryuichi Matsukawa; Toru Kubota; Masanori Okabe; Yusuke Yamamoto
Journal:  Heart Vessels       Date:  2015-12-16       Impact factor: 2.037

9.  Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.

Authors:  Akihisa Hanatani; Atsushi Shibata; Ryouko Kitada; Shinichi Iwata; Yoshiki Matsumura; Atsushi Doi; Kenichi Sugioka; Masahiko Takagi; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2016-07-06       Impact factor: 2.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.